Halozyme Therapeutics, Inc. (HALO)
USD 59.65
(-3.67%)
USD 59.65
(-3.67%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 1.49 Billion USD | 0.43% |
| 2022 | 1.49 Billion USD | 89.62% |
| 2021 | 787.25 Million USD | 22613.65% |
| 2020 | 3.46 Million USD | -99.1% |
| 2019 | 383.04 Million USD | 998.37% |
| 2018 | 34.87 Million USD | -72.13% |
| 2017 | 125.14 Million USD | -37.19% |
| 2016 | 199.22 Million USD | 612.27% |
| 2015 | 27.97 Million USD | -43.9% |
| 2014 | 49.86 Million USD | 0.18% |
| 2013 | 49.77 Million USD | 59.98% |
| 2012 | 31.11 Million USD | 0.0% |
| 2011 | - USD | 0.0% |
| 2010 | - USD | 0.0% |
| 2009 | - USD | 0.0% |
| 2008 | - USD | 0.0% |
| 2007 | - USD | 0.0% |
| 2006 | - USD | 0.0% |
| 2005 | - USD | 0.0% |
| 2004 | - USD | 0.0% |
| 2003 | - USD | 0.0% |
| 2002 | - USD | 0.0% |
| 2001 | - USD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 1.5 Billion USD | 0.11% |
| 2024 Q1 | 1.5 Billion USD | 0.11% |
| 2024 Q3 | 1.5 Billion USD | 0.11% |
| 2023 Q2 | 1.49 Billion USD | 0.11% |
| 2023 Q1 | 1.49 Billion USD | 0.11% |
| 2023 Q4 | 1.49 Billion USD | 0.11% |
| 2023 FY | 1.49 Billion USD | 0.43% |
| 2023 Q3 | 1.49 Billion USD | 0.11% |
| 2022 Q1 | 788.09 Million USD | 0.11% |
| 2022 Q3 | 1.49 Billion USD | 29.99% |
| 2022 FY | 1.49 Billion USD | 89.62% |
| 2022 Q2 | 1.14 Billion USD | 45.56% |
| 2022 Q4 | 1.49 Billion USD | 0.11% |
| 2021 Q2 | 785.57 Million USD | 0.11% |
| 2021 Q1 | 784.73 Million USD | 22540.83% |
| 2021 Q3 | 786.45 Million USD | 0.11% |
| 2021 Q4 | 787.25 Million USD | 0.1% |
| 2021 FY | 787.25 Million USD | 22613.65% |
| 2020 Q3 | 393.63 Million USD | 0.91% |
| 2020 Q4 | 3.46 Million USD | -99.12% |
| 2020 FY | 3.46 Million USD | -99.1% |
| 2020 Q1 | 386.57 Million USD | 0.92% |
| 2020 Q2 | 390.07 Million USD | 0.91% |
| 2019 FY | 383.04 Million USD | 998.37% |
| 2019 Q1 | 18.74 Million USD | -46.26% |
| 2019 Q2 | 14.08 Million USD | -24.86% |
| 2019 Q3 | 9.3 Million USD | -33.91% |
| 2019 Q4 | 383.04 Million USD | 4015.22% |
| 2018 FY | 34.87 Million USD | -72.13% |
| 2018 Q3 | 57.94 Million USD | -26.73% |
| 2018 Q4 | 34.87 Million USD | -39.81% |
| 2018 Q2 | 79.08 Million USD | -23.0% |
| 2018 Q1 | 102.69 Million USD | -17.94% |
| 2017 Q4 | 125.14 Million USD | -13.94% |
| 2017 Q2 | 165.51 Million USD | -10.25% |
| 2017 Q1 | 184.43 Million USD | -7.43% |
| 2017 Q3 | 145.41 Million USD | -12.14% |
| 2017 FY | 125.14 Million USD | -37.19% |
| 2016 Q4 | 199.22 Million USD | -0.29% |
| 2016 FY | 199.22 Million USD | 612.27% |
| 2016 Q2 | 204.85 Million USD | 21.5% |
| 2016 Q3 | 199.8 Million USD | -2.46% |
| 2016 Q1 | 168.6 Million USD | 502.77% |
| 2015 Q2 | 40.09 Million USD | -12.8% |
| 2015 FY | 27.97 Million USD | -43.9% |
| 2015 Q1 | 45.98 Million USD | -7.77% |
| 2015 Q4 | 27.97 Million USD | -17.96% |
| 2015 Q3 | 34.09 Million USD | -14.97% |
| 2014 Q4 | 49.86 Million USD | 25.4% |
| 2014 Q3 | 39.76 Million USD | -8.83% |
| 2014 Q2 | 43.61 Million USD | -7.97% |
| 2014 Q1 | 47.38 Million USD | -4.79% |
| 2014 FY | 49.86 Million USD | 0.18% |
| 2013 Q4 | 49.77 Million USD | 89.02% |
| 2013 Q3 | 26.33 Million USD | -6.54% |
| 2013 Q2 | 28.17 Million USD | -5.37% |
| 2013 Q1 | 29.77 Million USD | -4.3% |
| 2013 FY | 49.77 Million USD | 59.98% |
| 2012 Q2 | - USD | 0.0% |
| 2012 FY | 31.11 Million USD | 0.0% |
| 2012 Q3 | - USD | 0.0% |
| 2012 Q4 | 31.11 Million USD | 0.0% |
| 2012 Q1 | - USD | 0.0% |
| 2011 Q1 | - USD | 0.0% |
| 2011 Q4 | - USD | 0.0% |
| 2011 FY | - USD | 0.0% |
| 2011 Q3 | - USD | 0.0% |
| 2011 Q2 | - USD | 0.0% |
| 2010 Q4 | - USD | 0.0% |
| 2010 Q2 | - USD | 0.0% |
| 2010 Q3 | - USD | 0.0% |
| 2010 Q1 | - USD | 0.0% |
| 2010 FY | - USD | 0.0% |
| 2009 Q3 | - USD | 0.0% |
| 2009 FY | - USD | 0.0% |
| 2009 Q4 | - USD | 0.0% |
| 2009 Q2 | - USD | 0.0% |
| 2009 Q1 | - USD | 0.0% |
| 2008 Q4 | - USD | 0.0% |
| 2008 FY | - USD | 0.0% |
| 2008 Q1 | - USD | 0.0% |
| 2008 Q2 | - USD | 0.0% |
| 2008 Q3 | - USD | 0.0% |
| 2007 Q1 | - USD | 0.0% |
| 2007 FY | - USD | 0.0% |
| 2007 Q4 | - USD | 0.0% |
| 2007 Q3 | - USD | 0.0% |
| 2007 Q2 | - USD | 0.0% |
| 2006 Q1 | - USD | 0.0% |
| 2006 Q3 | - USD | 0.0% |
| 2006 Q4 | - USD | 0.0% |
| 2006 FY | - USD | 0.0% |
| 2006 Q2 | - USD | 0.0% |
| 2005 Q1 | - USD | 0.0% |
| 2005 Q4 | - USD | 0.0% |
| 2005 FY | - USD | 0.0% |
| 2005 Q3 | - USD | 0.0% |
| 2005 Q2 | - USD | 0.0% |
| 2004 Q2 | - USD | 0.0% |
| 2004 Q4 | - USD | 0.0% |
| 2004 Q3 | - USD | 0.0% |
| 2004 Q1 | - USD | 0.0% |
| 2004 FY | - USD | 0.0% |
| 2003 Q3 | - USD | 0.0% |
| 2003 Q2 | - USD | 0.0% |
| 2003 Q4 | - USD | 0.0% |
| 2003 Q1 | - USD | 0.0% |
| 2003 FY | - USD | 0.0% |
| 2002 Q3 | - USD | 0.0% |
| 2002 Q4 | - USD | 0.0% |
| 2002 Q1 | - USD | 0.0% |
| 2002 Q2 | - USD | 0.0% |
| 2002 FY | - USD | 0.0% |
| 2001 FY | - USD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| AbCellera Biologics Inc. | 71.22 Million USD | -2005.035% |
| Alkermes plc | 287.73 Million USD | -421.061% |
| Agenus Inc. | 137.32 Million USD | -991.76% |
| Alnylam Pharmaceuticals, Inc. | 2.34 Billion USD | 36.012% |
| Aptorum Group Limited | 3.05 Million USD | -48919.062% |
| Ardelyx, Inc. | 51.54 Million USD | -2808.507% |
| Arrowhead Pharmaceuticals, Inc. | 104.6 Million USD | -1333.206% |
| Bicycle Therapeutics plc | 40.08 Million USD | -3640.639% |
| BioXcel Therapeutics, Inc. | 100.59 Million USD | -1390.336% |
| ChromaDex Corporation | 2.57 Million USD | -58123.223% |
| Chimerix, Inc. | 125 Thousand USD | -1199298.4% |
| Corbus Pharmaceuticals Holdings, Inc. | 3.23 Million USD | -46192.646% |
| Caribou Biosciences, Inc. | 25.9 Million USD | -5686.815% |
| CRISPR Therapeutics AG | 223 Million USD | -572.287% |
| Precision BioSciences, Inc. | 7.72 Million USD | -19312.767% |
| Dyadic International, Inc. | 88.87 Thousand USD | -1686912.49% |
| Eton Pharmaceuticals, Inc. | 22 Thousand USD | -6814663.636% |
| Fortress Biotech, Inc. | 60.85 Million USD | -2363.599% |
| Lantern Pharma Inc. | 61.49 Thousand USD | -2437860.193% |
| HOOKIPA Pharma Inc. | 3.8 Million USD | -39343.515% |
| Inhibikase Therapeutics, Inc. | 90.12 Thousand USD | -1663439.124% |
| Incyte Corporation | 29.16 Million USD | -5041.101% |
| IO Biotech, Inc. | 1.83 Million USD | -81425.177% |
| Jaguar Health, Inc. | 30.99 Million USD | -4737.376% |
| Novavax, Inc. | 168.01 Million USD | -792.325% |
| Janux Therapeutics, Inc. | 23.02 Million USD | -6411.392% |
| Opthea Limited | 200.53 Million USD | -647.621% |
| Ligand Pharmaceuticals Incorporated | 5.75 Million USD | -25951.225% |
| ContextLogic Inc. | 6 Million USD | -24887.467% |
| MiMedx Group, Inc. | 48.09 Million USD | -3017.005% |
| Pyxis Oncology, Inc. | 20.09 Million USD | -7359.316% |
| TransCode Therapeutics, Inc. | 38.29 Thousand USD | -3915305.709% |
| NextCure, Inc. | 5.94 Million USD | -25101.681% |
| Ocuphire Pharma, Inc. | - USD | -Infinity% |
| Oncternal Therapeutics, Inc. | 145 Thousand USD | -1033864.138% |
| Outlook Therapeutics, Inc. | - USD | -Infinity% |
| Vaxcyte, Inc. | 22.11 Million USD | -6680.553% |
| PDS Biotechnology Corporation | 19.5 Million USD | -7586.014% |
| Madrigal Pharmaceuticals, Inc. | 115.48 Million USD | -1198.275% |
| Pharming Group N.V. | 166.1 Million USD | -802.591% |
| Pieris Pharmaceuticals, Inc. | - USD | -Infinity% |
| Avidity Biosciences, Inc. | 6.21 Million USD | -24030.822% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Sangamo Therapeutics, Inc. | 33.51 Million USD | -4373.364% |
| Sol-Gel Technologies Ltd. | 1.2 Million USD | -124215.755% |
| Acelyrin, Inc. | 1.19 Million USD | -125465.159% |
| Salarius Pharmaceuticals, Inc. | - USD | -Infinity% |
| SELLAS Life Sciences Group, Inc. | 460 Thousand USD | -325823.478% |
| Summit Therapeutics Inc. | 103.29 Million USD | -1351.494% |
| Sensei Biotherapeutics, Inc. | 3.76 Million USD | -39678.403% |
| Senti Biosciences, Inc. | 33.53 Million USD | -4370.296% |
| Stoke Therapeutics, Inc. | 4.77 Million USD | -31311.02% |
| Syros Pharmaceuticals, Inc. | 34.55 Million USD | -4238.604% |
| Alaunos Therapeutics, Inc. | - USD | -Infinity% |
| Telomir Pharmaceuticals, Inc. Common Stock | - USD | -Infinity% |
| Entrada Therapeutics, Inc. | 60.32 Million USD | -2385.45% |
| VistaGen Therapeutics, Inc. | 1.57 Million USD | -95393.503% |
| Wave Life Sciences Ltd. | 25.4 Million USD | -5801.622% |
| Sorrento Therapeutics, Inc. | 104.33 Million USD | -1336.915% |
| TRACON Pharmaceuticals, Inc. | 732 Thousand USD | -204715.301% |
| Barinthus Biotherapeutics plc | 11.19 Million USD | -13296.908% |
| Psyence Biomedical Ltd. | - USD | -Infinity% |
| Phathom Pharmaceuticals, Inc. | 138.3 Million USD | -984.024% |
| Immix Biopharma, Inc. | - USD | -Infinity% |
| Keros Therapeutics, Inc. | 13.43 Million USD | -11055.949% |
| MEI Pharma, Inc. | - USD | -Infinity% |
| Windtree Therapeutics, Inc. | 15 Million USD | -9894.987% |
| Xeris Biopharma Holdings, Inc. | 190.93 Million USD | -685.226% |
| Rigel Pharmaceuticals, Inc. | 52.65 Million USD | -2747.142% |
| Fortress Biotech, Inc. | 60.85 Million USD | -2363.599% |
| Precigen, Inc. | 5.89 Million USD | -25332.536% |
| Clearside Biomedical, Inc. | 41.98 Million USD | -3470.658% |
| AlloVir, Inc. | 16.64 Million USD | -8905.574% |
| C4 Therapeutics, Inc. | 65.75 Million USD | -2179.982% |
| Fate Therapeutics, Inc. | 97.36 Million USD | -1439.901% |
| ImmuCell Corporation | 10.54 Million USD | -14123.695% |
| IDEAYA Biosciences, Inc. | 1.12 Million USD | -133166.489% |
| Onconetix, Inc. | 118.85 Thousand USD | -1261288.055% |
| PureTech Health plc | 18.25 Million USD | -8115.058% |
| VYNE Therapeutics Inc. | 99 Thousand USD | -1514291.919% |
| Elevation Oncology, Inc. | 30.13 Million USD | -4874.775% |
| Kintara Therapeutics, Inc. | - USD | -Infinity% |
| Seer, Inc. | 25.96 Million USD | -5674.334% |
| Verrica Pharmaceuticals Inc. | 42.87 Million USD | -3396.87% |
| Innoviva, Inc. | 446.23 Million USD | -235.978% |
| Aadi Bioscience, Inc. | 833 Thousand USD | -179881.753% |
| ESSA Pharma Inc. | - USD | -Infinity% |
| GlycoMimetics, Inc. | 66.84 Thousand USD | -2242805.87% |
| GT Biopharma, Inc. | - USD | -Infinity% |
| Inhibrx Biosciences, Inc. | 206.96 Million USD | -624.386% |
| Akebia Therapeutics, Inc. | 71.19 Million USD | -2005.804% |
| Catalyst Pharmaceuticals, Inc. | 3.18 Million USD | -46927.854% |
| Longboard Pharmaceuticals, Inc. | - USD | -Infinity% |
| Orchestra BioMed Holdings, Inc. | 1.03 Million USD | -144336.224% |
| Alzamend Neuro, Inc. | - USD | -Infinity% |
| Rocket Pharmaceuticals, Inc. | 22.32 Million USD | -6615.256% |
| Aptose Biosciences Inc. | 621 Thousand USD | -241324.799% |
| ZyVersa Therapeutics, Inc. | - USD | -Infinity% |
| Soligenix, Inc. | 1.01 Million USD | -148203.252% |
| Century Therapeutics, Inc. | 46.65 Million USD | -3113.271% |
| Kura Oncology, Inc. | 9.33 Million USD | -15965.667% |
| TScan Therapeutics, Inc. | 26.7 Million USD | -5515.161% |
| Intensity Therapeutics, Inc. | 138 Thousand USD | -1086311.594% |
| Ocean Biomedical, Inc. | - USD | -Infinity% |
| CytomX Therapeutics, Inc. | 9.38 Million USD | -15874.939% |
| Autolus Therapeutics plc | 47.91 Million USD | -3029.04% |
| Mineralys Therapeutics, Inc. | - USD | -Infinity% |
| EyePoint Pharmaceuticals, Inc. | 4.9 Million USD | -30459.478% |
| Eterna Therapeutics Inc. | 6.77 Million USD | -22035.656% |
| Adaptive Biotechnologies Corporation | 130.66 Million USD | -1047.442% |
| GRI Bio, Inc. | - USD | -Infinity% |
| Xenetic Biosciences, Inc. | - USD | -Infinity% |
| Tenaya Therapeutics, Inc. | 8.1 Million USD | -18397.816% |
| IGM Biosciences, Inc. | 34.67 Million USD | -4224.089% |
| INmune Bio, Inc. | 397 Thousand USD | -377544.332% |
| Heron Therapeutics, Inc. | 173.75 Million USD | -762.862% |
| SAB Biotherapeutics, Inc. | 4.05 Million USD | -36879.572% |
| Pasithea Therapeutics Corp. | - USD | -Infinity% |
| Entero Therapeutics, Inc. | 146.94 Thousand USD | -1020150.563% |
| Milestone Pharmaceuticals Inc. | 49.77 Million USD | -2912.232% |
| X4 Pharmaceuticals, Inc. | 54.57 Million USD | -2647.385% |
| Atara Biotherapeutics, Inc. | 45.69 Million USD | -3181.133% |
| Coherus BioSciences, Inc. | 473.36 Million USD | -216.719% |
| Verastem, Inc. | 40.08 Million USD | -3640.079% |
| Abeona Therapeutics Inc. | 4.4 Million USD | -33958.337% |
| Pliant Therapeutics, Inc. | 10.05 Million USD | -14811.955% |
| Tonix Pharmaceuticals Holding Corp. | 6.56 Million USD | -22750.907% |
| Histogen Inc. | 4.38 Million USD | -34098.175% |
| Aprea Therapeutics, Inc. | - USD | -Infinity% |
| Surrozen, Inc. | 882 Thousand USD | -169882.766% |
| Organovo Holdings, Inc. | 888 Thousand USD | -168734.234% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Ovid Therapeutics Inc. | 30 Million USD | -4897.493% |
| Panbela Therapeutics, Inc. | 4.19 Million USD | -35647.449% |
| CASI Pharmaceuticals, Inc. | 18.89 Million USD | -7834.628% |
| Cadrenal Therapeutics, Inc. Common Stock | - USD | -Infinity% |
| Centessa Pharmaceuticals plc | 75.7 Million USD | -1880.513% |
| Hepion Pharmaceuticals, Inc. | 93.1 Thousand USD | -1610193.865% |
| Arcturus Therapeutics Holdings Inc. | 25.9 Million USD | -5687.038% |
| BioRestorative Therapies, Inc. | - USD | -Infinity% |
| Apollomics, Inc. | 267 Thousand USD | -561416.105% |
| Amarin Corporation plc | 8.73 Million USD | -17059.757% |
| Mesoblast Limited | 100.48 Million USD | -1392.041% |
| Turnstone Biologics Corp. | 1.18 Million USD | -125993.188% |
| Kymera Therapeutics, Inc. | 78.32 Million USD | -1814.04% |
| Synaptogenix, Inc. | - USD | -Infinity% |
| Tiziana Life Sciences Ltd | 109 Thousand USD | -1375356.881% |
| Aurinia Pharmaceuticals Inc. | 82 Million USD | -1728.151% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Monopar Therapeutics Inc. | - USD | -Infinity% |
| Exelixis, Inc. | 189.94 Million USD | -689.311% |
| Better Therapeutics, Inc. | 10.34 Million USD | -14388.288% |
| Nurix Therapeutics, Inc. | 23.12 Million USD | -6383.235% |
| Apellis Pharmaceuticals, Inc. | 93.03 Million USD | -1511.523% |
| NLS Pharmaceutics AG | - USD | -Infinity% |
| Dermata Therapeutics, Inc. | - USD | -Infinity% |
| Aridis Pharmaceuticals, Inc. | 1.29 Million USD | -115940.867% |
| Gritstone bio, Inc. | 40.14 Million USD | -3634.675% |
| Jasper Therapeutics, Inc. | 1.81 Million USD | -82548.732% |
| TNF Pharmaceuticals, Inc. | - USD | -Infinity% |
| Avid Bioservices, Inc. | 153.59 Million USD | -876.117% |
| Insmed Incorporated | 1.19 Billion USD | -25.633% |
| Virpax Pharmaceuticals, Inc. | - USD | -Infinity% |
| MediWound Ltd. | 6.35 Million USD | -23510.205% |
| OmniAb, Inc. | 22.07 Million USD | -6691.61% |
| Alector, Inc. | 30.45 Million USD | -4822.669% |
| Seres Therapeutics, Inc. | 101.54 Million USD | -1376.452% |
| Checkpoint Therapeutics, Inc. | - USD | -Infinity% |
| Viracta Therapeutics, Inc. | - USD | -Infinity% |
| Zai Lab Limited | 8.04 Million USD | -18531.142% |
| Revance Therapeutics, Inc. | 426.59 Million USD | -251.445% |
| Aura Biosciences, Inc. | 16.87 Million USD | -8787.066% |
| Lyell Immunopharma, Inc. | 56.89 Million USD | -2535.16% |
| Immunic, Inc. | 639 Thousand USD | -234524.1% |
| Tarsus Pharmaceuticals, Inc. | 29.81 Million USD | -4927.828% |
| Veracyte, Inc. | 7.52 Million USD | -19823.561% |
| InMed Pharmaceuticals Inc. | 644.86 Million USD | -132.49% |
| FibroGen, Inc. | 89.69 Million USD | -1571.458% |
| SeaStar Medical Holding Corporation | 4.33 Million USD | -34468.78% |
| Adial Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sonnet BioTherapeutics Holdings, Inc. | 130.86 Thousand USD | -1145562.257% |
| Jazz Pharmaceuticals plc | 5.1 Billion USD | 70.649% |
| Cyclacel Pharmaceuticals, Inc. | 37 Thousand USD | -4051921.622% |
| Amylyx Pharmaceuticals, Inc. | 1.98 Million USD | -75619.596% |
| TG Therapeutics, Inc. | 100.11 Million USD | -1397.481% |
| Galecto, Inc. | 66 Thousand USD | -2271487.879% |
| Calithera Biosciences, Inc. | 136 Thousand USD | -1102288.235% |
| Fortrea Holdings Inc. | 1.63 Billion USD | 8.157% |
| KalVista Pharmaceuticals, Inc. | 6.01 Million USD | -24825.154% |
| Aptevo Therapeutics Inc. | 5.39 Million USD | -27679.285% |
| XBiotech Inc. | - USD | -Infinity% |
| Jasper Therapeutics, Inc. | 1.81 Million USD | -82548.732% |
| Lyra Therapeutics, Inc. | 21.44 Million USD | -6890.479% |
| Foghorn Therapeutics Inc. | 36.55 Million USD | -4001.349% |
| Y-mAbs Therapeutics, Inc. | 517 Thousand USD | -289889.942% |
| Theravance Biopharma, Inc. | 45.23 Million USD | -3214.281% |
| Ultragenyx Pharmaceutical Inc. | 30.57 Million USD | -4803.67% |
| Metagenomi, Inc. Common Stock | 44.8 Million USD | -3246.386% |
| Vaxxinity, Inc. | 13.26 Million USD | -11204.841% |
| BioCryst Pharmaceuticals, Inc. | 811.26 Million USD | -84.804% |
| Gain Therapeutics, Inc. | 449.05 Thousand USD | -333768.831% |
| Cartesian Therapeutics, Inc. | 8.78 Million USD | -16958.232% |
| NexImmune, Inc. | - USD | -Infinity% |
| Creative Medical Technology Holdings, Inc. | - USD | -Infinity% |
| Marker Therapeutics, Inc. | - USD | -Infinity% |
| Regeneron Pharmaceuticals, Inc. | 2.7 Billion USD | 44.532% |
| Chemomab Therapeutics Ltd. | 316 Thousand USD | -474345.57% |
| Scopus BioPharma Inc. | - USD | -Infinity% |
| RAPT Therapeutics, Inc. | 4.45 Million USD | -33530.507% |
| Ainos, Inc. | 5.92 Million USD | -25218.48% |
| Pluri Inc. | 29.05 Million USD | -5060.39% |
| Prothena Corporation plc | 10.72 Million USD | -13884.218% |
| Adaptimmune Therapeutics plc | 19.85 Million USD | -7452.506% |
| Celularity Inc. | 26.17 Million USD | -5627.348% |
| Rallybio Corporation | 173 Thousand USD | -866517.341% |
| Cue Biopharma, Inc. | 4.2 Million USD | -35579.391% |
| MeiraGTx Holdings plc | 72.11 Million USD | -1978.853% |
| Omeros Corporation | 329.7 Million USD | -354.724% |
| Humacyte, Inc. | 38.6 Million USD | -3784.062% |
| Immunocore Holdings plc | 82.64 Million USD | -1714.104% |
| Cocrystal Pharma, Inc. | 1.61 Million USD | -92847.799% |
| Cidara Therapeutics, Inc. | 3.57 Million USD | -41813.559% |
| Blueprint Medicines Corporation | 610.96 Million USD | -145.391% |
| CalciMedica, Inc. | - USD | -Infinity% |
| Cabaletta Bio, Inc. | 1.45 Million USD | -102729.081% |
| Marinus Pharmaceuticals, Inc. | 95.18 Million USD | -1475.022% |
| Scholar Rock Holding Corporation | 48.68 Million USD | -2979.55% |
| Sana Biotechnology, Inc. | 90.9 Million USD | -1549.32% |
| Pulmatrix, Inc. | 8.32 Million USD | -17904.66% |
| Elicio Therapeutics, Inc. | 6 Million USD | -24858.349% |
| Vigil Neuroscience, Inc. | 12.94 Million USD | -11481.676% |
| Intellia Therapeutics, Inc. | 96.74 Million USD | -1449.658% |
| Adlai Nortye Ltd. American Depositary Shares | 469 Thousand USD | -319569.083% |
| Cytokinetics, Incorporated | 607.37 Million USD | -146.841% |
| Eloxx Pharmaceuticals, Inc. | 8.69 Million USD | -17148.596% |
| Nutriband Inc. | 79.82 Thousand USD | -1878044.965% |
| Protara Therapeutics, Inc. | 4.48 Million USD | -33335.504% |
| Vor Biopharma Inc. | 31.83 Million USD | -4610.173% |
| Roivant Sciences Ltd. | 477.85 Million USD | -213.745% |
| Evogene Ltd. | 10.65 Million USD | -13973.482% |
| ProKidney Corp. | 3.61 Million USD | -41430.416% |
| Applied Therapeutics, Inc. | 759 Thousand USD | -197429.381% |
| Hoth Therapeutics, Inc. | 26.32 Thousand USD | -5694832.766% |
| BridgeBio Pharma, Inc. | 1.73 Billion USD | 13.623% |
| CorMedix Inc. | 517.01 Thousand USD | -289882.65% |
| BioLineRx Ltd. | 6.62 Million USD | -22519.916% |
| Tango Therapeutics, Inc. | 36.83 Million USD | -3969.841% |
| Galectin Therapeutics Inc. | 71.74 Million USD | -1989.806% |
| Atai Life Sciences N.V. | 15.21 Million USD | -9756.341% |
| Renovaro Biosciences Inc. | 842.38 Thousand USD | -177875.733% |
| Aerovate Therapeutics, Inc. | 255 Thousand USD | -587840.392% |
| Zentalis Pharmaceuticals, Inc. | 43.15 Million USD | -3374.503% |
| Sagimet Biosciences Inc. | - USD | -Infinity% |
| MediciNova, Inc. | 410.66 Thousand USD | -364982.55% |
| Praxis Precision Medicines, Inc. | 1.36 Million USD | -109414.098% |
| Cardio Diagnostics Holdings, Inc. | 663.09 Thousand USD | -225997.159% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| Axsome Therapeutics, Inc. | 178.07 Million USD | -741.943% |
| Biomea Fusion, Inc. | 7.83 Million USD | -19047.484% |
| PTC Therapeutics, Inc. | 284.21 Million USD | -427.509% |
| Mereo BioPharma Group plc | 5.3 Million USD | -28187.698% |
| Cullinan Oncology, Inc. | 2.15 Million USD | -69632.465% |
| Syndax Pharmaceuticals, Inc. | 588 Thousand USD | -254874.15% |
| Absci Corporation | 4.66 Million USD | -32072.704% |
| NRx Pharmaceuticals, Inc. | - USD | -Infinity% |
| 4D Molecular Therapeutics, Inc. | 11.52 Million USD | -12912.047% |
| Dyne Therapeutics, Inc. | 22.69 Million USD | -6506.072% |
| Kiniksa Pharmaceuticals, Ltd. | 10 Million USD | -14884.988% |
| Ventyx Biosciences, Inc. | 11.5 Million USD | -12931.273% |
| Allakos Inc. | 38.21 Million USD | -3823.192% |
| Imunon, Inc. | 1.13 Million USD | -131494.594% |
| Fulcrum Therapeutics, Inc. | 8.62 Million USD | -17274.528% |
| Corcept Therapeutics Incorporated | - USD | -Infinity% |
| BioAtla, Inc. | 836 Thousand USD | -179235.885% |
| NLS Pharmaceutics AG | - USD | -Infinity% |
| Bio-Path Holdings, Inc. | 10 Thousand USD | -14992380.0% |
| Allogene Therapeutics, Inc. | 88.34 Million USD | -1597.019% |
| Larimar Therapeutics, Inc. | 4.7 Million USD | -31737.927% |
| XOMA Corporation | 118.51 Million USD | -1164.996% |
| Kezar Life Sciences, Inc. | 10.06 Million USD | -14789.741% |
| Cara Therapeutics, Inc. | 37.07 Million USD | -3943.388% |
| aTyr Pharma, Inc. | 13.76 Million USD | -10790.158% |
| Aligos Therapeutics, Inc. | 7.89 Million USD | -18880.225% |
| Akero Therapeutics, Inc. | 24.96 Million USD | -5905.64% |
| Viridian Therapeutics, Inc. | 20.2 Million USD | -7320.183% |
| Eliem Therapeutics, Inc. | 15 Thousand USD | -9994886.667% |
| EyeGate Pharmaceuticals, Inc. | 278.19 Thousand USD | -538829.509% |
| Akari Therapeutics, Plc | - USD | -Infinity% |
| Tevogen Bio Holdings Inc. | 14.45 Million USD | -10271.932% |
| Lexaria Bioscience Corp. | 136.17 Thousand USD | -1100887.714% |
| UroGen Pharma Ltd. | 98.55 Million USD | -1421.292% |
| Sutro Biopharma, Inc. | 149.11 Million USD | -905.437% |
| ZIVO Bioscience, Inc. | - USD | -Infinity% |
| Orgenesis Inc. | 19.06 Million USD | -7763.051% |
| Entera Bio Ltd. | 256 Thousand USD | -585543.75% |
| GH Research PLC | 631 Thousand USD | -237498.732% |
| Lisata Therapeutics, Inc. | 137.00 USD | -1094341505.839% |
| Reneo Pharmaceuticals, Inc. | 642 Thousand USD | -233427.726% |
| Xencor, Inc. | 14.64 Million USD | -10139.366% |
| 60 Degrees Pharmaceuticals, Inc. | 150.25 Thousand USD | -997728.966% |
| Replimune Group, Inc. | 71.99 Million USD | -1982.578% |
| Coeptis Therapeutics Holdings, Inc. | 150 Thousand USD | -999398.667% |
| Vanda Pharmaceuticals Inc. | 7 Million USD | -21299.486% |
| Lexaria Bioscience Corp. | 136.17 Thousand USD | -1100887.714% |
| Portage Biotech Inc. | 7000.00 USD | -21417728.571% |
| Cardio Diagnostics Holdings, Inc. | 663.09 Thousand USD | -225997.159% |
| Olema Pharmaceuticals, Inc. | 1.42 Million USD | -104815.885% |
| OncoCyte Corporation | 2.2 Million USD | -67923.956% |
| Qualigen Therapeutics, Inc. | - USD | -Infinity% |
| Processa Pharmaceuticals, Inc. | 66.9 Thousand USD | -2240760.922% |
| Purple Biotech Ltd. | 163 Thousand USD | -919684.049% |
| CollPlant Biotechnologies Ltd. | 2.53 Million USD | -59041.933% |
| scPharmaceuticals Inc. | 38.81 Million USD | -3762.946% |
| ProMIS Neurosciences, Inc. | - USD | -Infinity% |
| HilleVax, Inc. | 25.24 Million USD | -5839.027% |
| NeuroSense Therapeutics Ltd. | 73 Thousand USD | -2053664.384% |
| Tharimmune, Inc. | - USD | -Infinity% |
| Genprex, Inc. | - USD | -Infinity% |
| Neumora Therapeutics, Inc. Common Stock | 1.85 Million USD | -80809.228% |
| Atossa Therapeutics, Inc. | - USD | -Infinity% |
| XTL Biopharmaceuticals Ltd. | - USD | -Infinity% |
| Virios Therapeutics, Inc. | - USD | -Infinity% |
| OKYO Pharma Limited | - USD | -Infinity% |
| Savara Inc. | 26.34 Million USD | -5590.178% |
| Curis, Inc. | 1.48 Million USD | -100588.247% |
| Daré Bioscience, Inc. | 3.91 Million USD | -38207.923% |
| Carmell Therapeutics Corporation | 697.71 Thousand USD | -214779.714% |
| Titan Pharmaceuticals, Inc. | - USD | -Infinity% |
| Achieve Life Sciences, Inc. | 6000.00 USD | -24987366.667% |
| BeiGene, Ltd. | 197.61 Million USD | -658.66% |
| Kiromic BioPharma, Inc. | 911.5 Thousand USD | -164381.404% |
| Revolution Medicines, Inc. Warrant | 80.57 Million USD | -1760.686% |
| Protagonist Therapeutics, Inc. | - USD | -Infinity% |
| Erasca, Inc. | 51.88 Million USD | -2789.337% |
| bluebird bio, Inc. | 224.41 Million USD | -568.058% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| BioMarin Pharmaceutical Inc. | 593.09 Million USD | -152.784% |
| DBV Technologies S.A. | 4.52 Million USD | -33025.232% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| Moderna, Inc. | - USD | -Infinity% |
| Vincerx Pharma, Inc. | 1.34 Million USD | -111784.179% |
| Fresh Tracks Therapeutics, Inc. | - USD | -Infinity% |
| Molecular Templates, Inc. | 9.74 Million USD | -15289.53% |
| Acrivon Therapeutics, Inc. Common Stock | 3.76 Million USD | -39699.522% |
| Travere Therapeutics, Inc. | 377.26 Million USD | -297.401% |
| Monte Rosa Therapeutics, Inc. | 42.87 Million USD | -3396.625% |
| Spruce Biosciences, Inc. | 1.71 Million USD | -87217.88% |
| Celldex Therapeutics, Inc. | 928 Thousand USD | -161456.897% |
| Cogent Biosciences, Inc. | 17.46 Million USD | -8483.317% |
| MacroGenics, Inc. | 30.19 Million USD | -4865.055% |
| RenovoRx, Inc. | - USD | -Infinity% |
| Adicet Bio, Inc. | 17.7 Million USD | -8368.892% |
| Prime Medicine, Inc. | 4.35 Million USD | -34310.099% |
| Aditxt, Inc. | 1.04 Million USD | -143817.124% |
| Adagene Inc. | 13.54 Million USD | -10972.705% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 13.73 Million USD | -10813.94% |
| Maravai LifeSciences Holdings, Inc. | 518.7 Million USD | -189.036% |
| Acurx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Voyager Therapeutics, Inc. | 17.09 Million USD | -8671.123% |
| SciSparc Ltd. | 24 Thousand USD | -6246766.667% |
| Vericel Corporation | 81.85 Million USD | -1731.568% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Minerva Neurosciences, Inc. | 82.01 Million USD | -1727.976% |
| Generation Bio Co. | 89.77 Million USD | -1570.025% |
| Astria Therapeutics, Inc. | - USD | -Infinity% |
| Black Diamond Therapeutics, Inc. | 22.18 Million USD | -6657.936% |
| Arcutis Biotherapeutics, Inc. | 201.79 Million USD | -642.941% |
| Invivyd, Inc. | 722 Thousand USD | -207552.078% |
| Relay Therapeutics, Inc. | 48.5 Million USD | -2991.106% |
| Quoin Pharmaceuticals, Ltd. | 2923.73 USD | -51278506.438% |
| Spero Therapeutics, Inc. | 3.82 Million USD | -39096.026% |
| Artelo Biosciences, Inc. | 23 Thousand USD | -6518369.565% |
| 2seventy bio, Inc. | 244.01 Million USD | -514.413% |
| ADMA Biologics, Inc. | 130.59 Million USD | -1048.022% |
| Clene Inc. | 7.15 Million USD | -20862.64% |
| Capricor Therapeutics, Inc. | 3.37 Million USD | -44305.598% |
| Boundless Bio, Inc. Common Stock | 247.61 Million USD | -505.471% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| Recursion Pharmaceuticals, Inc. | 1.1 Million USD | -136071.48% |
| Citius Pharmaceuticals, Inc. | 262.86 Thousand USD | -570249.038% |
| Contineum Therapeutics, Inc. Class A Common Stock | 192.62 Million USD | -678.345% |
| Relmada Therapeutics, Inc. | - USD | -Infinity% |
| Finch Therapeutics Group, Inc. | 28.4 Million USD | -5178.485% |
| ALX Oncology Holdings Inc. | 9.63 Million USD | -15453.979% |
| Vir Biotechnology, Inc. | 111.67 Million USD | -1242.534% |
| Evaxion Biotech A/S | 8.48 Million USD | -17561.589% |
| Ocular Therapeutix, Inc. | 74.92 Million USD | -1900.998% |
| Verve Therapeutics, Inc. | 64.71 Million USD | -2216.693% |
| Trevena, Inc. | 35.23 Million USD | -4155.238% |
| Surrozen, Inc. | 882 Thousand USD | -169882.766% |
| Tyra Biosciences, Inc. | 6.21 Million USD | -24019.176% |
| Cingulate Inc. | 135.09 Thousand USD | -1109640.265% |
| Galmed Pharmaceuticals Ltd. | - USD | -Infinity% |
| Unity Biotechnology, Inc. | 23.53 Million USD | -6269.209% |
| Tenax Therapeutics, Inc. | - USD | -Infinity% |
| Terns Pharmaceuticals, Inc. | - USD | -Infinity% |
| ACADIA Pharmaceuticals Inc. | 47.8 Million USD | -3036.502% |
| Connect Biopharma Holdings Limited | 180 Thousand USD | -832815.556% |
| Clearmind Medicine Inc. | - USD | -Infinity% |
| Kronos Bio, Inc. | 25.37 Million USD | -5807.435% |
| Bolt Biotherapeutics, Inc. | 17.43 Million USD | -8498.085% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Viking Therapeutics, Inc. | 936 Thousand USD | -160076.068% |
| Statera Biopharma, Inc. | 11.43 Million USD | -13015.472% |
| ImmunityBio, Inc. | 836.95 Million USD | -79.132% |
| Korro Bio, Inc. | 31.21 Million USD | -4702.819% |
| Kineta, Inc. | 150 Thousand USD | -999398.667% |
| BioVie Inc. | 349.89 Thousand USD | -428386.342% |
| Codexis, Inc. | 12.24 Million USD | -12145.757% |
| Celularity Inc. | 26.17 Million USD | -5627.348% |
| Crinetics Pharmaceuticals, Inc. | 47.55 Million USD | -3052.661% |
| Celcuity Inc. | 37.03 Million USD | -3948.147% |
| Virax Biolabs Group Limited | 176.34 Thousand USD | -850078.911% |
| Cibus, Inc. | 17.67 Million USD | -8382.788% |
| Eledon Pharmaceuticals, Inc. | - USD | -Infinity% |
| eFFECTOR Therapeutics, Inc. | - USD | -Infinity% |
| IN8bio, Inc. | 3.37 Million USD | -44269.577% |
| Kodiak Sciences Inc. | 100 Million USD | -1399.248% |
| Annexon, Inc. | 29.19 Million USD | -5036.17% |
| Adverum Biotechnologies, Inc. | 64.62 Million USD | -2219.848% |
| Assembly Biosciences, Inc. | 1.12 Million USD | -133522.816% |
| Avalo Therapeutics, Inc. | 2 Million USD | -74862.4% |
| Ionis Pharmaceuticals, Inc. | 1.4 Billion USD | -7.06% |
| Eyenovia, Inc. | 8.95 Million USD | -16637.851% |
| Puma Biotechnology, Inc. | 65.65 Million USD | -2183.385% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| Xilio Therapeutics, Inc. | 8.14 Million USD | -18313.756% |
| Arcellx, Inc. | 50.84 Million USD | -2848.896% |
| Cardiff Oncology, Inc. | 1.45 Million USD | -102729.081% |
| Enanta Pharmaceuticals, Inc. | 21.23 Million USD | -6959.271% |
| Regulus Therapeutics Inc. | 1.05 Million USD | -142008.815% |
| Moolec Science SA | 99.04 Thousand USD | -1513588.589% |
| Acumen Pharmaceuticals, Inc. | 27.62 Million USD | -5327.928% |
| Geron Corporation | 35.05 Million USD | -4177.333% |
| LAVA Therapeutics N.V. | 591 Thousand USD | -253579.865% |
| Royalty Pharma plc | 6.13 Billion USD | 75.564% |
| Atea Pharmaceuticals, Inc. | 1.64 Million USD | -91206.212% |
| Greenwich LifeSciences, Inc. | - USD | -Infinity% |
| TFF Pharmaceuticals, Inc. | 31.74 Thousand USD | -4723131.05% |
| Mersana Therapeutics, Inc. | 23.14 Million USD | -6376.793% |
| Humacyte, Inc. | 38.6 Million USD | -3784.062% |
| Structure Therapeutics Inc. | 4.01 Million USD | -37259.781% |
| 89bio, Inc. | 24.79 Million USD | -5946.574% |
| PMV Pharmaceuticals, Inc. | 12.43 Million USD | -11957.648% |
| Avenue Therapeutics, Inc. | - USD | -Infinity% |
| Genelux Corporation | 1.86 Million USD | -80245.552% |
| Trevi Therapeutics, Inc. | 1.03 Million USD | -145175.969% |
| Lexicon Pharmaceuticals, Inc. | 99.5 Million USD | -1406.661% |
| Notable Labs, Ltd. | 1.52 Million USD | -98146.92% |
| Liquidia Corporation | 2.36 Million USD | -63319.966% |
| Mustang Bio, Inc. | 1.97 Million USD | -75696.158% |
| Immunovant, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 13.73 Million USD | -10813.94% |
| Arbutus Biopharma Corporation | 6.95 Million USD | -21462.606% |
| DiaMedica Therapeutics Inc. | 317 Thousand USD | -472848.896% |
| Vera Therapeutics, Inc. | 49.87 Million USD | -2905.89% |
| Acasti Pharma Inc. | - USD | -Infinity% |
| MiNK Therapeutics, Inc. | - USD | -Infinity% |
| Pasithea Therapeutics Corp. | - USD | -Infinity% |
| Xenon Pharmaceuticals Inc. | 9.6 Million USD | -15510.662% |
| Elevai Labs, Inc. Common Stock | 65.48 Thousand USD | -2289212.709% |
| NeuroBo Pharmaceuticals, Inc. | 136 Thousand USD | -1102288.235% |
| Tempest Therapeutics, Inc. | 6.26 Million USD | -23834.355% |
| Soleno Therapeutics, Inc. | 130 Thousand USD | -1153167.692% |
| PepGen Inc. | 17.1 Million USD | -8667.532% |
| Moleculin Biotech, Inc. | 474 Thousand USD | -316197.046% |
| United Therapeutics Corporation | 300 Million USD | -399.749% |
| Nuvectis Pharma, Inc. | - USD | -Infinity% |
| Solid Biosciences Inc. | 23.94 Million USD | -6162.261% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Immuneering Corporation | 4.16 Million USD | -35914.924% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Silo Pharma, Inc. | - USD | -Infinity% |
| Belite Bio, Inc | 578 Thousand USD | -259285.467% |
| XOMA Corporation | 118.51 Million USD | -1164.996% |
| ARS Pharmaceuticals, Inc. | 37 Thousand USD | -4051921.622% |
| Bionomics Limited | 117.62 Million USD | -1174.567% |
| Apogee Therapeutics, Inc. | 933 Thousand USD | -160591.104% |
| Alpha Tau Medical Ltd. | 5.61 Million USD | -26624.563% |
| uniQure N.V. | 130.06 Million USD | -1052.691% |
| Cassava Sciences, Inc. | - USD | -Infinity% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Poseida Therapeutics, Inc. | 58.59 Million USD | -2458.88% |
| Forte Biosciences, Inc. | - USD | -Infinity% |
| Anebulo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Enlivex Therapeutics Ltd. | 686 Thousand USD | -218449.271% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| SeaStar Medical Holding Corporation | 4.33 Million USD | -34468.78% |
| FibroBiologics, Inc. Common Stock | 1.38 Million USD | -108148.953% |
| Altimmune, Inc. | 175 Thousand USD | -856613.143% |
| Amicus Therapeutics, Inc. | 387.85 Million USD | -286.546% |
| Alpha Tau Medical Ltd. | 5.61 Million USD | -26624.563% |
| Compugen Ltd. | 719 Thousand USD | -208418.498% |
| Peak Bio, Inc. | - USD | -Infinity% |
| Zevra Therapeutics, Inc. | 5.06 Million USD | -29494.315% |
| Benitec Biopharma Inc. | - USD | -Infinity% |
| Spyre Therapeutics, Inc. | 84.55 Million USD | -1673.104% |
| NKGen Biotech, Inc. Common Stock | 9.93 Million USD | -14998.167% |
| Zura Bio Limited | - USD | -Infinity% |
| PolyPid Ltd. | 6.37 Million USD | -23402.869% |
| Aileron Therapeutics, Inc. | 91.41 Million USD | -1540.136% |
| NKGen Biotech, Inc. Warrants | 9.93 Million USD | -14998.167% |
| Instil Bio, Inc. | 81.42 Million USD | -1741.217% |
| argenx SE | 15.35 Million USD | -9664.543% |
| Immunome, Inc. | 1.34 Million USD | -111784.179% |
| Compass Therapeutics, Inc. | 536 Thousand USD | -279610.448% |
| Verona Pharma plc | 48.37 Million USD | -2999.285% |
| enGene Holdings Inc. Warrants | 9.21 Million USD | -16167.882% |
| Shattuck Labs, Inc. | 3.4 Million USD | -43917.851% |
| CervoMed Inc. | - USD | -Infinity% |
| LENZ Therapeutics, Inc. | - USD | -Infinity% |
| Plus Therapeutics, Inc. | 85 Thousand USD | -1763721.176% |
| Dianthus Therapeutics, Inc. | 168 Thousand USD | -892309.524% |
| Moolec Science SA | 99.04 Thousand USD | -1513588.589% |
| Enveric Biosciences, Inc. | - USD | -Infinity% |
| Inovio Pharmaceuticals, Inc. | 11.03 Million USD | -13489.911% |
| AnaptysBio, Inc. | 16.03 Million USD | -9248.681% |
| Design Therapeutics, Inc. | 2.33 Million USD | -64135.133% |
| Leap Therapeutics, Inc. | - USD | -Infinity% |
| NeurAxis, Inc. | 27.07 Thousand USD | -5538106.937% |
| Seelos Therapeutics, Inc. | - USD | -Infinity% |
| Lumos Pharma, Inc. | 6 Million USD | -24887.467% |
| Achilles Therapeutics plc | 1.07 Million USD | -139235.316% |
| enGene Holdings Inc. Common Stock | 9.21 Million USD | -16167.882% |
| 180 Life Sciences Corp. | 19.93 Thousand USD | -7520204.976% |
| Opiant Pharmaceuticals, Inc. | 16.74 Million USD | -8854.78% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Nutriband Inc. | 79.82 Thousand USD | -1878044.965% |
| ORIC Pharmaceuticals, Inc. | 7461.00 USD | -20094364.549% |
| CG Oncology, Inc. Common stock | 13 Thousand USD | -11532576.923% |
| Fractyl Health, Inc. Common Stock | 342.48 Million USD | -337.76% |
| Rani Therapeutics Holdings, Inc. | 24.48 Million USD | -6023.379% |
| MoonLake Immunotherapeutics | 2.49 Million USD | -59870.16% |
| Palisade Bio, Inc. | 90 Thousand USD | -1665731.111% |
| Tourmaline Bio, Inc. | 194 Thousand USD | -772708.247% |
| Beam Therapeutics Inc. | 159.91 Million USD | -837.552% |
| Neurogene Inc. | 13.37 Million USD | -11111.007% |
| Mirum Pharmaceuticals, Inc. | 306.42 Million USD | -389.277% |
| AEON Biopharma, Inc. | - USD | -Infinity% |
| CARGO Therapeutics, Inc. Common Stock | 26.26 Million USD | -5608.594% |
| Sesen Bio, Inc. | - USD | -Infinity% |
| Enliven Therapeutics, Inc. | - USD | -Infinity% |
| Kiora Pharmaceuticals, Inc. | 59.82 Thousand USD | -2506081.672% |
| Iovance Biotherapeutics, Inc. | 1 Million USD | -149824.8% |
| Taysha Gene Therapies, Inc. | 40.5 Million USD | -3601.116% |
| Athira Pharma, Inc. | 1.21 Million USD | -123092.112% |
| Vaccinex, Inc. | 26 Thousand USD | -5766238.462% |
| HCW Biologics Inc. | 6.3 Million USD | -23681.288% |
| XOMA Corporation | 118.51 Million USD | -1164.996% |
| Nektar Therapeutics | 112.62 Million USD | -1231.186% |
| Arvinas, Inc. | 800 Thousand USD | -187306.0% |
| Tevogen Bio Holdings Inc. | 14.45 Million USD | -10271.932% |
| Merus N.V. | 10.48 Million USD | -14194.889% |
| Omega Therapeutics, Inc. | 14.88 Million USD | -9972.207% |
| Quince Therapeutics, Inc. | 13.42 Million USD | -11064.256% |
| Rezolute, Inc. | 1.66 Million USD | -90216.145% |
| Clene Inc. | 7.15 Million USD | -20862.64% |
| Indaptus Therapeutics, Inc. | 73.34 Thousand USD | -2043920.287% |
| BeyondSpring Inc. | 3.36 Million USD | -44467.42% |
| Synlogic, Inc. | 12.49 Million USD | -11902.626% |
| Allarity Therapeutics, Inc. | - USD | -Infinity% |
| Phio Pharmaceuticals Corp. | - USD | -Infinity% |
| Peak Bio, Inc. | - USD | -Infinity% |
| Werewolf Therapeutics, Inc. | 32.65 Million USD | -4491.034% |
| Krystal Biotech, Inc. | 6.62 Million USD | -22547.251% |
| Karyopharm Therapeutics Inc. | 170.91 Million USD | -777.169% |
| SpringWorks Therapeutics, Inc. | 5.99 Million USD | -24904.136% |
| Lipella Pharmaceuticals Inc. | 47.37 Thousand USD | -3164806.8% |
| MannKind Corporation | 252.15 Million USD | -494.583% |
| Ikena Oncology, Inc. | 7.18 Million USD | -20780.891% |
| Cyclerion Therapeutics, Inc. | - USD | -Infinity% |
| Gyre Therapeutics, Inc. | 199 Thousand USD | -753290.955% |
| Gossamer Bio, Inc. | 197.4 Million USD | -659.478% |
| CohBar, Inc. | - USD | -Infinity% |
| Cognition Therapeutics, Inc. | 520 Thousand USD | -288216.923% |
| NRx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Legend Biotech Corporation | 281.32 Million USD | -432.918% |
| Mural Oncology plc | 8.91 Million USD | -16724.689% |
| Biora Therapeutics, Inc. | 43.73 Million USD | -3327.95% |
| PaxMedica, Inc. Common Stock | - USD | -Infinity% |
| Disc Medicine, Inc. | 1.43 Million USD | -104304.457% |
| Champions Oncology, Inc. | 6.09 Million USD | -24506.073% |
| REGENXBIO Inc. | 82.22 Million USD | -1723.415% |
| Ensysce Biosciences, Inc. | - USD | -Infinity% |
| Anavex Life Sciences Corp. | - USD | -Infinity% |
| Cellectar Biosciences, Inc. | 494 Thousand USD | -303389.655% |
| Edgewise Therapeutics, Inc. | 4.43 Million USD | -33712.539% |
| Vaxart, Inc. | 2.62 Million USD | -57057.758% |
| PharmaCyte Biotech, Inc. | - USD | -Infinity% |
| Aldeyra Therapeutics, Inc. | 271.63 Thousand USD | -551842.893% |
| Cellectis S.A. | 36.24 Million USD | -4036.884% |
| Longeveron Inc. | 1.44 Million USD | -103439.227% |
| Repare Therapeutics Inc. | 1.01 Million USD | -148340.396% |
| Sarepta Therapeutics, Inc. | 1.13 Billion USD | -32.382% |
| Inozyme Pharma, Inc. | 44.76 Million USD | -3248.853% |
| Revolution Medicines, Inc. | 80.57 Million USD | -1760.686% |
| Nymox Pharmaceutical Corporation | - USD | -Infinity% |
| Third Harmonic Bio, Inc. | 3.2 Million USD | -46634.663% |
| ArriVent BioPharma, Inc. Common Stock | 177 Thousand USD | -846932.768% |
| AN2 Therapeutics, Inc. | - USD | -Infinity% |
| Anixa Biosciences, Inc. | 123 Thousand USD | -1218800.813% |
| Vertex Pharmaceuticals Incorporated | 724.7 Million USD | -106.878% |
| Denali Therapeutics Inc. | 44.98 Million USD | -3233.07% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Veru Inc. | 12.5 Million USD | -11889.907% |
| Corvus Pharmaceuticals, Inc. | - USD | -Infinity% |
| Cingulate Inc. | 135.09 Thousand USD | -1109640.265% |
| Passage Bio, Inc. | 22.92 Million USD | -6440.936% |
| Context Therapeutics Inc. | - USD | -Infinity% |
| Exicure, Inc. | 6.03 Million USD | -24726.097% |
| Day One Biopharmaceuticals, Inc. | - USD | -Infinity% |
| Oramed Pharmaceuticals Inc. | 647 Thousand USD | -231623.029% |
| Scinai Immunotherapeutics Ltd. | 20.16 Million USD | -7334.902% |
| Rhythm Pharmaceuticals, Inc. | 490 Thousand USD | -305868.98% |
| Nuvalent, Inc. | - USD | -Infinity% |
| ABVC BioPharma, Inc. | 407.45 Thousand USD | -367852.447% |
| Carisma Therapeutics, Inc. | 1.18 Million USD | -126099.327% |
| Unicycive Therapeutics, Inc. | 466 Thousand USD | -321627.039% |
| OmniAb, Inc. | 22.07 Million USD | -6691.61% |
| Anew Medical, Inc. | 1.54 Million USD | -97253.766% |
| Fennec Pharmaceuticals Inc. | 29.55 Million USD | -4971.884% |
| Lipocine Inc. | - USD | -Infinity% |
| Lexeo Therapeutics, Inc. Common Stock | 9.03 Million USD | -16497.454% |
| Nautilus Biotechnology, Inc. | 31.09 Million USD | -4722.284% |
| SAB Biotherapeutics, Inc. | 4.05 Million USD | -36879.572% |
| G1 Therapeutics, Inc. | 51.55 Million USD | -2807.943% |
| Bellerophon Therapeutics, Inc. | - USD | -Infinity% |
| Sage Therapeutics, Inc. | - USD | -Infinity% |
| Ocugen, Inc. | 6.36 Million USD | -23447.165% |
| Mind Medicine (MindMed) Inc. | 14.12 Million USD | -10511.14% |
| Q32 Bio Inc. | - USD | -Infinity% |
| Brainstorm Cell Therapeutics Inc. | 672 Thousand USD | -223002.381% |
| Alumis Inc. Common Stock | 30.86 Million USD | -4758.224% |
| Equillium, Inc. | 384 Thousand USD | -390329.167% |
| Kyverna Therapeutics, Inc. | 6.15 Million USD | -24242.393% |
| Coya Therapeutics, Inc. | - USD | -Infinity% |
| CNS Pharmaceuticals, Inc. | - USD | -Infinity% |
| Galera Therapeutics, Inc. | 151.04 Million USD | -892.557% |
| Evelo Biosciences, Inc. | 48.87 Million USD | -2967.264% |
| Comera Life Sciences Holdings, Inc. | 120.3 Thousand USD | -1246136.97% |
| Dominari Holdings Inc. | 3.02 Million USD | -49412.814% |
| Edesa Biotech, Inc. | 19.77 Thousand USD | -7582199.095% |
| vTv Therapeutics Inc. | 169 Thousand USD | -887028.994% |
| Bio-Techne Corporation | 319 Million USD | -369.984% |
| Agios Pharmaceuticals, Inc. | 56.98 Million USD | -2530.814% |
| Harmony Biosciences Holdings, Inc. | 178.56 Million USD | -739.604% |
| Prelude Therapeutics Incorporated | 15.4 Million USD | -9630.953% |
| Candel Therapeutics, Inc. | 12.38 Million USD | -12007.308% |
| iTeos Therapeutics, Inc. | 4.8 Million USD | -31088.85% |
| Nkarta, Inc. | 82.27 Million USD | -1722.351% |
| BioCardia, Inc. | 982 Thousand USD | -152572.912% |
| Iterum Therapeutics plc | 18.95 Million USD | -7809.095% |